In this study, we discovered that high ATP13A3 expression is associated with worse overall and event‐free survival in neuroblastoma patients and that ATP13A3, but not SLC3A2, is a primary mediator of DFMO‐induced polyamine uptake in this disease. Here, SLC3A2 is linked to neuroblastoma.